1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Hematoma, Subdural in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, S; Hirashima, Y; Nagahori, T; Nakagawa, Y; Nishijima, M; Takaku, A | 1 |
| Endo, S; Hirasima, Y; Karasawa, K; Kato, R; Nagahori, T; Nishijima, M; Nojima, S; Ohmori, T; Takaku, A | 1 |
| Endo, S; Hayashi, N; Hirashima, Y; Karasawa, K; Nojima, S; Takaku, A | 1 |
| Odawara, M; Tamaoka, A; Yamashita, K | 1 |
4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hematoma, Subdural
| Article | Year |
|---|---|
Analysis of plasma and hematoma lipids related to choline glycerophospholipid in patients with chronic subdural hematoma.
Topics: Aged; Cell Aggregation; Cerebrovascular Circulation; Chronic Disease; Female; Hematoma, Subdural; Humans; Lipids; Male; Middle Aged; Phosphatidylcholines; Platelet Activating Factor | 1994 |
Platelet-activating factor (PAF) and the development of chronic subdural haematoma.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Fluorescent Antibody Technique; Hematoma, Subdural; Humans; Male; Middle Aged; Phospholipases A; Platelet Activating Factor | 1994 |
Platelet-activating factor (PAF) and the formation of chronic subdural haematoma. Measurement of plasma PAF levels and anti-PAF immunoglobulin titers.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Chronic Disease; Female; Follow-Up Studies; Hematoma, Subdural; Humans; Immunoglobulin G; Male; Middle Aged; Platelet Activating Factor; Reference Values | 1995 |
Ginkgo biloba.
Topics: Adult; Female; Hematoma, Subdural; Humans; Magnetic Resonance Imaging; Plant Extracts; Platelet Activating Factor; Recurrence | 1997 |